The presented invention is related to a vaccine, a pharmaceutical composition, a carrier for nucleic acids and for other biologically active substances, use of composition in vaccine manufacturing and use of cationic derivatives of PTAI in production of immunomodulating substances. More specifically, the presented invention is related to use of carriers based on cationic derivatives of polyprenols used as DNA vaccine carriers, easily transported and stored.
